Literature DB >> 7708737

Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes.

C A Thrash-Bingham1, R E Greenberg, S Howard, A Bruzel, M Bremer, A Goll, H Salazar, J J Freed, K D Tartof.   

Abstract

The von Hippel-Lindau locus on chromosome 3p is a tumor suppressor gene known to be involved in nonpapillary renal cell carcinoma. A previous loss of heterozygosity (LOH) study aimed at determining the allelotype of kidney tumors has indicated that in addition to 3p, chromosome arms 5q, 6q, 10q, 11q, 17p, and 19p may also harbor tumor suppressor genes. However, cytogenetic studies reveal that chromosomes 3p, 6q, 8p, 9pq, and 14q most frequently undergo karyotypic changes in renal tumors. To resolve these differences, a collection of microsatellite DNA probes has been used to scan for LOH so that 90% of individual tumor genomes were rendered informative for allele loss. The assay is capable of detecting quantitative genomic alterations in tumor cells as well. We find that LOH is most frequent for chromosome arm 3p. However, in no tumor is 3p exclusively affected. LOH for 6q, 8p, 9pq, and 14q is also distinctly elevated for both nonpapillary as well as papillary tumors and suggest that many of the tumor suppressor loci involved may be common to the etiology of both forms of kidney cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7708737      PMCID: PMC42317          DOI: 10.1073/pnas.92.7.2854

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Mapping small DNA sequences by fluorescence in situ hybridization directly on banded metaphase chromosomes.

Authors:  Y S Fan; L M Davis; T B Shows
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  The 1993-94 Généthon human genetic linkage map.

Authors:  G Gyapay; J Morissette; A Vignal; C Dib; C Fizames; P Millasseau; S Marc; G Bernardi; M Lathrop; J Weissenbach
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

3.  Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas.

Authors:  G Kovacs; S Frisch
Journal:  Cancer Res       Date:  1989-02-01       Impact factor: 12.701

4.  Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases.

Authors:  G Kovacs
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

5.  Expression of recessive alleles by chromosomal mechanisms in retinoblastoma.

Authors:  W K Cavenee; T P Dryja; R A Phillips; W F Benedict; R Godbout; B L Gallie; A L Murphree; L C Strong; R L White
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

6.  Hereditary renal-cell carcinoma associated with a chromosomal translocation.

Authors:  A J Cohen; F P Li; S Berg; D J Marchetto; S Tsai; S C Jacobs; R S Brown
Journal:  N Engl J Med       Date:  1979-09-13       Impact factor: 91.245

7.  Relationship between serum and histochemical markers for hepatitis B virus and rate of viral integration in hepatocellular carcinomas in Japan.

Authors:  O Hino; T Kitagawa; H Sugano
Journal:  Int J Cancer       Date:  1985-01-15       Impact factor: 7.396

8.  Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma.

Authors:  B Zbar; H Brauch; C Talmadge; M Linehan
Journal:  Nature       Date:  1987 Jun 25-Jul 1       Impact factor: 49.962

9.  Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis.

Authors:  G Kovacs; L Wilkens; T Papp; W de Riese
Journal:  J Natl Cancer Inst       Date:  1989-04-05       Impact factor: 13.506

10.  Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization.

Authors:  D Pinkel; T Straume; J W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more
  18 in total

1.  Loss of heterozygosity of the nm23-H1 gene in human renal cell carcinomas.

Authors:  M H Bosnar; K Pavelić; R Hrasćan; Z Zeljko; I Krhen; Z Marekoyic; S Krizanac; J Pavelíc
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  NF-κB inhibition by bortezomib permits IFN-γ-activated RIP1 kinase-dependent necrosis in renal cell carcinoma.

Authors:  Roshan J Thapa; Peirong Chen; Mitchell Cheung; Shoko Nogusa; Jianming Pei; Suraj Peri; Joseph R Testa; Siddharth Balachandran
Journal:  Mol Cancer Ther       Date:  2013-05-08       Impact factor: 6.261

3.  Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients.

Authors:  Chiara Grisanzio; Apryle Seeley; Michelle Chang; Michael Collins; Arianna Di Napoli; Su-Chun Cheng; Andrew Percy; Rameen Beroukhim; Sabina Signoretti
Journal:  J Pathol       Date:  2011-06-27       Impact factor: 7.996

4.  CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A.

Authors:  P Schraml; K Struckmann; R Bednar; W Fu; T Gasser; K Wilber; J Kononen; G Sauter; M J Mihatsch; H Moch
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 5.  Renal cell carcinoma.

Authors:  Paul Cairns
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

6.  Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays.

Authors:  R Mei; P C Galipeau; C Prass; A Berno; G Ghandour; N Patil; R K Wolff; M S Chee; B J Reid; D J Lockhart
Journal:  Genome Res       Date:  2000-08       Impact factor: 9.043

Review 7.  Loss of heterozygosity analyzed by single nucleotide polymorphism array in cancer.

Authors:  Hai-Tao Zheng; Zhi-Hai Peng; Sheng Li; Lin He
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

8.  Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features.

Authors:  J Bjornsson; M P Short; D J Kwiatkowski; E P Henske
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

9.  Loss of heterozygosity and methylation of p16 in renal cell carcinoma.

Authors:  M T Sanz-Casla; M L Maestro; V del Barco; I Zanna; J Moreno; M Vidaurreta; I Almansa; C Fernández; J Blanco; C Maestro; L Resel
Journal:  Urol Res       Date:  2003-03-25

10.  Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma.

Authors:  Melinda E Sanders; Rosemarie Mick; John E Tomaszewski; Frederic G Barr
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.